✦ LIBER ✦

528 CARBOPLATIN-BASED NEOADJUVANT CHEMOTHERAPY: A REASONABLE ALTERNATIVE FOR CISPLATIN UNFIT PATIENTS?

✍ Scribed by Mertens, Laura; Meijer, Richard; van Rhijn, Bas; Bergman, Andries; Kerst, Martijn; Horenblas, Simon

Book ID: 118485307
Publisher: Lippincott Williams and Wilkins
Year: 2012
Tongue: English
Weight: 126 KB
Volume: 187
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2012.02.601

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Carboplatin Based Induction Chemotherapy

Carboplatin Based Induction Chemotherapy for Nonorgan Confined Bladder Cancer—A Reasonable Alternative for Cisplatin Unfit Patients?

✍ Mertens, Laura S.; Meijer, Richard P.; Kerst, J. Martijn; Bergman, Andries M.; v 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 621 KB

865 Carboplatin-based neoadjuvant chemot

865 Carboplatin-based neoadjuvant chemotherapy for non-organ confined bladder cancer: An useful regimen in cisplatin-unfit patients?

✍ L.S. Mertens; R.P. Meijer; B.W. Van Rhijn; A.M. Bergman; J.M. Kerst; A. Bex; H.G 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 16 KB

A consensus definition of patients with

A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy

✍ Matthew D Galsky; Noah M Hahn; Jonathan Rosenberg; Guru Sonpavde; Thomas Hutson; 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 153 KB

Re: Randomized Phase II/III Trial Assess

Re: Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986

✍ Taneja, Samir S. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 124 KB

Carboplatin, methotrexate, and vinblasti

Carboplatin, methotrexate, and vinblastine in patients with bladder cancer who were ineligible for cisplatin-based chemotherapy

✍ J. Bellmunt; J. Albanell; O. S. Gallego; A. Ribas; P. Vicente; J. Carulla; J. De 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 622 KB

Background. A Phase I1 trial with a new regimen of methotrexate, carboplatin, and vinblastine (M-CAVI) was conducted for patients with bladder cancer who could not receive cisplatin-based chemotherapy. Methods. Treatment consisted of methotrexate (30 mg/m2) on days 1,15, and 22; carboplatin (300 mg

Combination of gemcitabine and carboplat

Combination of gemcitabine and carboplatin as first line treatment in elderly patients or those unfit for cisplatin-based chemotherapy with advanced transitional cell carcinoma of the urinary tract

✍ Joo Hee Park, Soon Wook Lee, Hye Sook Kim… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 239 KB